Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ynkszlr
    Junior Member
    • Oct 2024
    • 2

    #1

    Can iHS and XP-EHH be applied to targeted sequencing data?

    Hey everyone!

    I’m working with a dataset of samples from three different populations, sequenced using targeted amplicon panels covering 48 genes. Although most iHS and XP-EHH analyses are typically done using whole-genome data, I’m exploring whether it's still meaningful to apply these haplotype-based selection scans to targeted sequencing data.

    So far, I’ve phased the VCF using Beagle and used scikit-allel in Python to calculate XP-EHH between the two populations. Some positions show extreme values (>2 or <–2), but many remain inconclusive or missing, likely due to SNP density and regional limitations. I also attempted iHS per population, but the sparse data posed challenges. In addition to these, I’ve also performed Fst, Tajima’s D, and PCA to explore population structure and signatures of selection. My main question is: Can iHS and XP-EHH still offer valid insights when applied to datasets that only cover small portions of the genome? I’m aware of the caveats but curious if anyone has experience or recommendations when working with non-WGS data in this context.

    Appreciate any thoughts or references!

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    Today, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 05:39 AM
0 responses
10 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 09:56 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 09-29-2026, 09:51 AM
0 responses
77 views
0 reactions
Last Post SEQadmin2  
Working...